Selected Peer-Reviewed Publications and Collaborative Research Outputs.
Publications listed in this section include at least one author carrying an NBIIC-HI institutional affiliation.
Selected peer-reviewed publications carrying an NBIIC-HI institutional affiliation reflect the breadth of research conducted by the Institute's researchers and international collaborators. These publications span diverse areas of biomedical science, clinical medicine, translational research, healthcare innovation, data-driven discovery, and emerging interdisciplinary fields.
Through collaboration with researchers, clinicians, universities, hospitals, research institutions, and innovation partners across different disciplines and regions, NBIIC-HI supports a broad and evolving portfolio of scholarly research and collaborative outputs.
International Immunopharmacology.
Research Area: Extracellular vesicles; targeted delivery; immunoregulation; liver cancer.
Cancer Cell International.
Research Area: Tumor microenvironment; Kupffer cells; CD47; liver metastasis.
JMA Journal.
Research Area: MASH; insulin resistance; hypertension; integrative genomics; causal mediation.
Bioengineering-Basel.
Research Area: Protease-resistant peptides; non-canonical amino acids; peptide engineering; peptide therapeutics; synthetic biology; biosynthetic engineering.
Medicine Advances.
Research Area: Xenotransplantation; Kidney injury; Single-cell RNA sequencing; Renal biology.
Frontiers in Pharmacology.
Research Area: Epitranscriptomics; ALKBH5-targeted drug discovery; molecular docking; cancer therapy.
Selected representative publications published before the establishment of NBIIC-HI by researchers currently associated with the Institute and selected core collaborators are presented to provide academic context and reflect the scholarly foundations supporting the Institute's development.
Research Areas: Hepatocellular carcinoma; immune checkpoint blockade; pH-sensitive nanoparticles; siRNA delivery; immunosuppressive tumor microenvironment.
Research Areas: Colorectal cancer; cancer stem cells; epigenetic regulation; NR5A2; NANOG; tumor stemness; therapeutic targeting.
Research Areas: Rheumatoid arthritis; machine learning; drug repurposing; artificial intelligence; translational drug discovery.
Research Areas: Ischemic stroke; gut–brain immune axis; ILC2 migration; neuroinflammation; intestinal barrier; DNAH9; natural-product therapeutics.
Research Areas: Intestinal mucosal barrier; glycolytic reprogramming; circRNA; miR-200b-3p/IGF2 axis; intestinal epithelial repair; metabolic regulation.
Research Areas: Alveolar bone regeneration; exosome-loaded hydrogels; hUCMSC-derived exosomes; osteogenic differentiation; angiogenesis; miR-21-5p; WWP1/KLF5 and ATP2B4 signaling.
Research Areas: Engineered exosomes; controlled drug delivery; MXene-based biomaterials; photothermal therapy; regenerative medicine; wound repair.
Research Areas: Urinary retention; drug safety; pharmacovigilance; Mendelian randomization; urological adverse events.
Research Areas: Prostate-specific antigen; pharmacovigilance; adverse drug reactions; Mendelian randomization; real-world data.
Research Areas: Breast cancer; carbon dots; single-atom nanozymes; catalytic therapy; chemotherapy; nanomedicine.
Research Areas: Cancer immunotherapy; immunogenic biomaterials; immune cell trafficking; immune modulation.
Research Areas: Colorectal cancer; fatty liver–tumor interaction; M2 macrophage polarization; lipid metabolism reprogramming; extracellular vesicles; tumor microenvironment; MAPKAP1 signaling.
Research Areas: Clear-cell renal cell carcinoma; neoadjuvant targeted therapy; tumor heterogeneity; ferroptosis; therapeutic resistance.
Research Areas: Cervical cancer; MELK signaling; NF-κB/IL-6 axis; Th1/Th2 polarization; CD8⁺ T-cell immunity; PD-1 blockade; tumor immune microenvironment.
Research Areas: Hepatocellular carcinoma; transcatheter arterial chemoembolisation; targeted therapy; treatment response; clinical prognosis.
Research Areas: Rheumatoid arthritis; gut microbiome; metabolomics; mucosal immunity; Th17 cells; fecal microbiota transplantation.
Research Areas: Pediatric IgA nephropathy; long noncoding RNA; miR-196b-5p; PTEN; JNK/c-Jun signaling; molecular therapeutics.
Research Areas: Microbiome–immune regulation; intestinal inflammation; metabolite-sensing receptors; Ffar2 signaling; translational immunology.
Research Areas: NEDDylation; NEDD8-activating enzyme; targeted cancer therapy; clinical translation; drug development.
Research Areas: Lung adenocarcinoma; tumor microenvironment; M2 macrophage polarization; lncRNA-mediated epigenetic regulation; TET1-dependent DNA methylation; LINC00240; CSF1 signaling.
Research Areas: Myocardial fibrosis; circular RNA; m6A modification; FTO; miR-636; DKK2; cardiovascular translational research.
Research Areas: Dermatomyositis; polymyositis; regulatory T cells; low-dose IL-2; immune restoration.
Research Areas: Systemic lupus erythematosus; gut microbiome; metabolites; immune dysregulation; biomarkers; microbiota-based intervention.
Research Areas: Clear-cell renal cell carcinoma; SDHB; glycolysis; tumor metabolism; therapeutic targets.
Research Areas: Medicinal chemistry; NEDDylation pathway; small-molecule discovery; anticancer agents; in vitro and in vivo validation.
Research Areas: Osteosarcoma; microRNA regulation; cisplatin-induced apoptosis; JMJD2C; HIF1α/HES1 signaling; epigenetic regulation; chemotherapy sensitization.
Research Areas: Hepatocellular carcinoma; CRISPR/Cas9 gene editing; epigenetic regulation; NSD1; H3K27me3; Wnt10b; Wnt/β-catenin signaling.
Research Areas: Cervical cancer; chemotherapy sensitivity; cytosolic phospholipase A2α; β-catenin signaling; therapeutic resistance.
Research Areas: Breast cancer; Cyclin D1; microRNA signatures; prognostic biomarkers; precision oncology.
Research Areas: Golgi biology; hormone secretion; glucose homeostasis; metabolic regulation; mouse models.
